Posts by: Tim J. Smith, PhD

Quest Diagnostics Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Quest Diagnostics, a U.S. healthcare diagnostic company, had a positive FY 2024. Revenue rose 6.7% to $9.87 billion, and earnings before interest…

More

Edwards Lifesciences Corporation Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Edwards Lifesciences, a global leader in structural heart innovation, reported a positive FY 2024. Revenue rose 8.6% to $5.4 billion and earnings…

More

LabCorp Holdings Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

LabCorp, a laboratory services company for medical providers, pharmaceuticals, and researchers, had a positive FY 2024. Revenue rose 7% to $13.0 billion,…

More

Moderna Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Moderna, a leader in mRNA medicine best known for its COVID vaccine, had a mixed FY 2024. Revenue fell 53% to $3.2…

More

Where and When is the Inflationary Impact of Tariffs?

By Tim J. Smith, PhD October 1, 2025

Tariffs are in the news, but will they have no to little impact on inflation? What can we expect in the next…

More

Bristol-Myers Squibb Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Bristol-Myers Squibb, a global biopharmaceutical company, had a mixed FY 2024. Revenue rose 7.3% to $48.3 billion while operating earnings fell 199%…

More

Regeneron Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Regeneron, a biotechnology company, had a mixed FY 2024. Revenue rose 8.3% to $14.2 billion, while operating profit fell 3.6% to $4.0…

More

Baxter Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Baxter, a global healthcare product company, had a mixed FY 2024. Revenue rose 2.7% to $10.6 billion, while operating income fell 98%…

More

Improve Price Discipline and Value Capture at Our Company

By Tim J. Smith, PhD September 3, 2025

Challenge Our pricing is challenged by discipline and predictability in capturing our fair share of the value we deliver to customers. Recommendation…

More

Benchmarks and Recommended Size for the Pricing Function

By Tim J. Smith, PhD September 3, 2025

How large should a company’s pricing team be? How should executives and consultants even benchmark the size of a pricing team across…

More

About The Author

timjsmith
Tim J. Smith, PhD, is the founder and CEO of Wiglaf Pricing, an Adjunct Professor of Marketing and Economics at DePaul University, and the author of Pricing Done Right (Wiley 2016) and Pricing Strategy (Cengage 2012). At Wiglaf Pricing, Tim leads client engagements. Smith’s popular business book, Pricing Done Right: The Pricing Framework Proven Successful by the World’s Most Profitable Companies, was noted by Dennis Stone, CEO of Overhead Door Corp, as "Essential reading… While many books cover the concepts of pricing, Pricing Done Right goes the additional step of applying the concepts in the real world." Tim’s textbook, Pricing Strategy: Setting Price Levels, Managing Price Discounts, & Establishing Price Structures, has been described by independent reviewers as “the most comprehensive pricing strategy book” on the market. As well as serving as the Academic Advisor to the Professional Pricing Society’s Certified Pricing Professional program, Tim is a member of the American Marketing Association and American Physical Society. He holds a BS in Physics and Chemistry from Southern Methodist University, a BA in Mathematics from Southern Methodist University, a PhD in Physical Chemistry from the University of Chicago, and an MBA with high honors in Strategy and Marketing from the University of Chicago GSB.